Abstract:Objective: This study is aimed to screen, identify and detect illegal additives from healthcare products which claim or imply to have weight-loss effects. Method: Ultra-high performance liquid chromatography-quadruple-time-of-flight mass spectroscopy (UPLC-Q-TOF/MS) was employed to perform non-targeted screening of illegal additives from a total of 26 batches of healthcare products with weight-loss effects. A novel oxyphenisatin dipropionate analog was discovered in a fruit-flavored jelly that was not clearly labeled as containing added drugs. After being separated and purified by silica gel column chromatography, the analog was unambiguously characterized by one-dimensional (1D) and two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopies. The molecular structure of the analog was finally identified by comparing the spectra of the analog with those of suspected candidates prepared by de novo synthesis strategy. Thereafter, a sensitive and precise reversed phase ultra performance liquid chromatography coupled with photodiode array (UPLC-PDA) detection method was developed and verified for the determination of the analog in 15 batches of real samples. Results: In the MS/MS spectra, the signal intensity of mass/charge ratios (m/z, 242 and 214) of the novel analog fragments was highly similar to that of mass/charge ratios (m/z, 224 and 196) of oxyphenisatin dipropionate fragments. Additionally, the 1D NMR spectrum of the analog was completely consistent with that of one of the suspected candidates prepared by the de novo synthesis strategy. Based on the above analysis, the structure of the analog was determined as 3,3-bis[4'-(propionyloxy)phenyl]-6-fluoro-2-oxoindoline, which was briefly named 6-F oxyphenisatin dipropionate. A developed quantitative method showed good linearity (R2 > 0.999) in a concentration range of 1.0-100 μg/mL. The limits of detection (LOD) and quantification (LOQ) for the analog was 3 mg/kg and 10 mg/kg, respectively. The average recoveries of the analog from spiked three different matrix samples in low (1 time of LOQ), medium (2 times of LOQ), and high (10 times of LOQ) concentrations were varied from 93.9 % to 107.8 % with a precision of 0.03-1.56 %. Results of quantitative analysis in 15 batches of healthcare products revealed that the content of 6-F oxyphenisatin dipropionate in a fruit-flavored jelly and a solid beverage was 118 mg/kg and 330 mg/kg, respectively. Conclusion: In terms of its structure, 6-F oxyphenisatin dipropionate replaces hydrogen atom by the fluorine atom at position 6 on the indolinone fragment in oxyphenisatin dipropionate. To our best knowledge, 6-F oxyphenisatin dipropionate has never been detected as an illegal additive in foods. Such illegal addition of the analog to foods is more concealing, thus the supervision and testing departments should attach great importance to its application in food markets.

Identifying N-nitrosofenfluramine in a Nutrition Supplement.

Analysis of trace amounts of adulterants found in powders/supplements utilizing Raman spectroscopy coupled to direct analyte-probed nanoextraction-nanospray ionization-mass spectrometry.

Identification of fenfluramine adulteration in slimming foods using a highly sensitive immunoassay

Determination of N-nitroso folic acid in folic acid and multivitamin supplements by LC-MS/MS

The application of 19F NMR spectroscopy for the analysis of fluorinated new psychoactive substances (NPS)

Analysis Of 8 Synthetic Anorexics In Adulterated Weight-Reducing Tonic

Identification of the New Psychoactive Substance Eutylone.

Determination of nitrofuran metabolites in meat products by UHPLC-fluorescence with ultrasonic-assisted derivatization

Rapid and accurate quantification and analysis of nitrofuran metabolites residues in aquatic products by ultra-high performance liquid chromatography–tandem mass spectrometry

Syringe cleanup with UHPLC-MS/MS for nitroimidazoles and steroids detection in manure-based fertilizers.

Simultaneous Determination of Adulterants in Dietary Food Supplements Using Multivariate Data Analysis after Preconcentration with Novel Nanosorbents and Chromatographic Measurement

Stereoselective Determination of Fenfluramine Enantiomers in Rat Liver Microsomal Incubates

Analysis of metabolites of nitrofuran antibiotics in animal-derived food by UPLC-MS/MS

Rapid Characterization of an Unknown Impurity in Bulk Drug Levofloxacin Carboxylic Acid by High Performance Liquid Chromatography/mass Spectrometry

Isolation, characterization, identification and quantification of 6-F oxyphenisatin dipropionate, a novel illegal additive, from a fruit-flavored jelly

A new derivatizing reagent for the determination of 5-nitro-2-furaldehyde in trout muscle by liquid chromatography-tandem mass spectrometry

Identification of Dimethylamphetamine in a Suspect Exhibit

Separation and characterization of the impurities in 3,3-diamino-4,4-azoxyfurazan by ultrahigh-performance liquid chromatography combined with Q‐orbitrap mass spectrometry

STUDY OF MASS SPECTRUM CHARACTERIZATION OF THE BENZOFURANONE COMPOUNDS

Identification of Flurochloridone Metabolites in Rat Urine Using Liquid Chromatography/high Resolution Mass Spectrometry.

Determination of four nitrofuran metabolites in gelatin Chinese medicine using dispersive solid phase extraction and pass-through solid phase extraction coupled to ultra high performance liquid chromatography-tandem mass spectrometry